Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Stopped Study closed following Phase I portion, insufficient activity to continue to Phase II.
Conditions
- Solid Tumor
- Thyroid Cancer
Interventions
- DRUG: Capecitabine (Xeloda)
- DRUG: DTIC-Dome (Dacarbazine)
- DRUG: Gleevec (Imatinib Mesylate)
Sponsor
M.D. Anderson Cancer Center
Collaborators